• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚首例新冠病毒肺炎患者长时间住院后严重神经症状良好恢复的病例

First Australian Case of Good Recovery of a COVID-19 Patient With Severe Neurological Symptoms Post Prolonged Hospitalization.

作者信息

Wijeratne Tissa, Sales Carmela A, Crewther Sheila G, Nguyen Vinh, Karimi Leila

机构信息

Department of Neurology, Australian Institute for Musculoskeletal Science, Western Centre for Health Research & Education, Melbourne Medical School, Sunshine Hospital Western Health, St Albans, AUS.

Department of Psychology and Public Health, La Trobe University, Bundoora, AUS.

出版信息

Cureus. 2020 Sep 10;12(9):e10366. doi: 10.7759/cureus.10366.

DOI:10.7759/cureus.10366
PMID:33062489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7549849/
Abstract

A case of a 75-year-old man with COVID-19, severe neurological symptoms (acute stroke-like symptoms and signs and full recovery after a prolonged hospital stay), and intracranial hypertension is discussed with an in-depth review of his clinical features, biochemistry, haematology, highlighting the relationship between changes in neutrophil-lymphocyte ratio, C-reactive protein level, D-dimer level, and the clinical onset of acute ischemic stroke-like symptoms in the setting of COVID-19 and major neurological manifestations. This is the first such case reported in Australia to date. This case also illustrates the recovery of a patient with COVID-19 complicated with severe neurological symptoms (acute ischemic stroke-like symptoms) during the prolonged intensive care unit stay (at day 26) followed by slow neurorehabilitation and normal recovery from both respiratory and neurological involvement. The onset of acute stroke-like symptoms appears to be closely associated with changes of neutrophil-lymphocyte ratio and in C-reactive protein, and D-dimer levels.

摘要

讨论了一例75岁男性新冠肺炎患者,该患者有严重的神经症状(急性中风样症状和体征,住院时间延长后完全康复)及颅内高压,并对其临床特征、生物化学、血液学进行了深入回顾,重点强调了在新冠肺炎背景下中性粒细胞与淋巴细胞比值、C反应蛋白水平、D-二聚体水平的变化与急性缺血性中风样症状临床发作及主要神经表现之间的关系。这是澳大利亚迄今为止报道的首例此类病例。该病例还说明了一名新冠肺炎合并严重神经症状(急性缺血性中风样症状)的患者在重症监护病房长时间住院期间(第26天)的康复情况,随后进行了缓慢的神经康复治疗,呼吸和神经方面的病变均实现了正常康复。急性中风样症状的发作似乎与中性粒细胞与淋巴细胞比值以及C反应蛋白和D-二聚体水平的变化密切相关。

相似文献

1
First Australian Case of Good Recovery of a COVID-19 Patient With Severe Neurological Symptoms Post Prolonged Hospitalization.澳大利亚首例新冠病毒肺炎患者长时间住院后严重神经症状良好恢复的病例
Cureus. 2020 Sep 10;12(9):e10366. doi: 10.7759/cureus.10366.
2
Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review.COVID-19相关急性缺血性卒中:一项基于病例的系统评价
Front Neurol. 2020 Sep 25;11:1031. doi: 10.3389/fneur.2020.01031. eCollection 2020.
3
New-onset acute ischemic stroke following COVID-19: A case-control study.新型冠状病毒肺炎(COVID-19)后新发急性缺血性卒中:一项病例对照研究。
J Res Med Sci. 2022 Apr 15;27:31. doi: 10.4103/jrms.jrms_255_21. eCollection 2022.
4
Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department.新型冠状病毒肺炎(COVID-19)伴有新发神经症状患者的预后因素:罗马尼亚某神经内科的一项回顾性队列研究
Front Aging Neurosci. 2021 Jun 17;13:645611. doi: 10.3389/fnagi.2021.645611. eCollection 2021.
5
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation.接受强化神经康复治疗的与COVID-19相关的感染后神经综合征患者的临床和电生理结果指标
Front Neurol. 2021 Mar 12;12:643713. doi: 10.3389/fneur.2021.643713. eCollection 2021.
6
Myoclonus status revealing COVID 19 infection.肌阵挛状态揭示 COVID-19 感染。
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
7
Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.缺血性脑卒中患者 rtPA 和/或血栓切除术前后中性粒细胞/淋巴细胞、血小板比值的变化及其与 NIHSS 的关系。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):105004. doi: 10.1016/j.jstrokecerebrovasdis.2020.105004. Epub 2020 Jun 14.
8
The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke.急性缺血性脑卒中患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及淋巴细胞与单核细胞比值与溶栓后早期神经功能结局的相关性
J Neuroinflammation. 2021 Feb 20;18(1):51. doi: 10.1186/s12974-021-02090-6.
9
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.随机临床试验评估 COVID-19 住院患者使用恢复期血浆的安全性和疗效(PERUCONPLASMA):一项随机对照试验研究方案的结构化总结。
Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.
10
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.

引用本文的文献

1
Serial Systemic Immune-Inflammation Indices (SSIIi) as Prognostic Markers in Persistent Hypoxic Brain Injury Post-cardiac Arrest: A Case Report.连续系统性免疫炎症指数(SSIIi)作为心脏骤停后持续性缺氧性脑损伤的预后标志物:一例报告
Cureus. 2024 Aug 20;16(8):e67299. doi: 10.7759/cureus.67299. eCollection 2024 Aug.
2
Secondary headaches - red and green flags and their significance for diagnostics.继发性头痛——警示信号及其在诊断中的意义。
eNeurologicalSci. 2023 Jun 30;32:100473. doi: 10.1016/j.ensci.2023.100473. eCollection 2023 Sep.
3
Associations of the neutrophil/lymphocyte ratio, monocyte/ lymphocyte ratio, and platelet/lymphocyte ratio with COVID-19 disease severity in patients with neurological symptoms: A cross-sectional monocentric study.

本文引用的文献

1
Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.新冠肺炎病例中的免疫炎症参数:一项系统评价与荟萃分析
Front Med (Lausanne). 2020 Jun 9;7:301. doi: 10.3389/fmed.2020.00301. eCollection 2020.
2
SARS-CoV-2 and Stroke in a New York Healthcare System.SARS-CoV-2 与纽约医疗体系中的中风。
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
3
Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management.COVID-19 的临床病程、神经系统表现及其治疗的一些思考。
中性粒细胞/淋巴细胞比值、单核细胞/淋巴细胞比值和血小板/淋巴细胞比值与伴有神经症状的COVID-19患者疾病严重程度的相关性:一项横断面单中心研究。
J Neurosci Rural Pract. 2023 Apr-Jun;14(2):224-229. doi: 10.25259/JNRP_6_2022. Epub 2022 Oct 22.
4
Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis.长期 COVID-19 综合征中的持续性神经表现:系统评价和荟萃分析。
J Infect Public Health. 2022 Aug;15(8):856-869. doi: 10.1016/j.jiph.2022.06.013. Epub 2022 Jun 23.
5
The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients.AIFELL评分作为住院患者2019冠状病毒病(COVID-19)严重程度和病情进展的预测指标
Diagnostics (Basel). 2022 Feb 27;12(3):604. doi: 10.3390/diagnostics12030604.
6
Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study.一组埃及新冠肺炎患者的神经学表现:一项前瞻性、多中心、观察性研究。
Brain Sci. 2022 Jan 1;12(1):74. doi: 10.3390/brainsci12010074.
7
Frailty in Stroke-A Narrated Review.卒中中的衰弱——叙述性综述
Life (Basel). 2021 Aug 28;11(9):891. doi: 10.3390/life11090891.
8
Systemic thrombolysis in ischaemic stroke patients with COVID-19.COVID-19 缺血性脑卒中患者的系统性溶栓治疗。
Acta Neurol Scand. 2022 Jan;145(1):47-52. doi: 10.1111/ane.13520. Epub 2021 Aug 20.
9
Neurological Complications of COVID-19: Underlying Mechanisms and Management.新型冠状病毒肺炎相关神经系统并发症:发病机制与治疗。
Int J Mol Sci. 2021 Apr 15;22(8):4081. doi: 10.3390/ijms22084081.
10
Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS).新冠后神经综合征(PCNS)背景下连续系统性免疫炎症指标(SSIIi)的临床应用价值
J Neurol Sci. 2021 Apr 15;423:117356. doi: 10.1016/j.jns.2021.117356. Epub 2021 Feb 20.
Stroke Vasc Neurol. 2020 Jun;5(2):177-179. doi: 10.1136/svn-2020-000398. Epub 2020 May 4.
4
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
5
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.COVID-19 相关严重高凝状态与急性呼吸衰竭入住重症监护病房患者。
Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.
6
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病:预防、抗栓治疗与随访的相关问题:美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
7
Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.脑血管病与 2019 年冠状病毒病(COVID-19)患者的疾病严重程度增加相关:已发表文献的汇总分析。
Int J Stroke. 2020 Jun;15(4):385-389. doi: 10.1177/1747493020921664. Epub 2020 Apr 20.
8
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
9
Six-month Longitudinal Comparison of a Portable Tablet Perimeter With the Humphrey Field Analyzer.便携式平板电脑与 Humphrey 视野分析仪的 6 个月纵向比较。
Am J Ophthalmol. 2018 Jun;190:9-16. doi: 10.1016/j.ajo.2018.03.009. Epub 2018 Mar 14.
10
Tablets at the bedside - iPad-based visual field test used in the diagnosis of Intrasellar Haemangiopericytoma: a case report.床边平板电脑——基于iPad的视野检查在鞍内血管外皮细胞瘤诊断中的应用:一例报告
BMC Ophthalmol. 2017 Apr 24;17(1):53. doi: 10.1186/s12886-017-0445-z.